Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00947440 · ClinicalTrials.gov registry record · Phase 1
Evaluation of the Bioavailability of Two ABT-072 Tablet Formulations as Compared to ABT-072 Capsule Formulation
A Phase 1 study, sponsored by Abbott.
- Completed
- Registry status
- Phase 1
- Development phase
- 18
- Enrollment target
NCT00947440 is a Phase 1 study that has completed, run by Abbott. The registered enrollment target is 18 participants.
The verdict
NCT00947440, a Phase 1 study, has completed, sponsored by Abbott.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 18 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the bioavailability, safety, tolerability and pharmacokinetics of two tablet formulations as compared to the capsule formulation suspended in liquid.
Interventions
- DRUG ABT-072
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2009-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00947440
The ClinicalTrials.gov registry entry for NCT00947440 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott, which has 181 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ABT-072 is the first listed.
NCT00947440 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00947440 about?
NCT00947440 is a clinical study titled "Evaluation of the Bioavailability of Two ABT-072 Tablet Formulations as Compared to ABT-072 Capsule Formulation". The purpose of this study is to assess the bioavailability, safety, tolerability and pharmacokinetics of two tablet formulations as compared to the capsule formulation suspended in liquid.
What is the current status of trial NCT00947440?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 18 participants. The study started on 2009-07.
What interventions are being tested in trial NCT00947440?
The interventions under investigation include: ABT-072 (DRUG).
Who is sponsoring clinical trial NCT00947440?
This trial is sponsored by Abbott, which has 181 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.